Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Alyson Saben on the Eyes, Ears, and Muscle Behind FDA's Efforts to Protect Public Health.
Alyson Saben on the Eyes, Ears, and Muscle Behind FDA's Efforts to Protect Public Health.
Dr. Dianne Murphy on Effective and Proper Uses of Medicines and Devices in Children
Dr. Dianne Murphy on Effective and Proper Uses of Medicines and Devices in Children
Tim Coté on Orphan Drugs and the Fight Against Rare Diseases
Tim Coté on Orphan Drugs and the Fight Against Rare Diseases
John Jenkins on Changes in the Way New Drugs are Evaluated.
John Jenkins on Changes in the Way New Drugs are Evaluated.
Communicating Benefit and Risk Information
Communicating Benefit and Risk Information
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
